| Literature DB >> 34026344 |
Tamara Chavez-Lindell1, Agricola Odoi1, Bob Kikwe2, Anthony Gikonyo2.
Abstract
BACKGROUND: Cardiac surgeries are high risk procedures that require specialized care and access to these procedures is often limited in resource-poor countries. Although fatalities for surgical patients across Africa are twice that of the global rate, cardiac surgical mortality continent-wide is only slightly higher than all-surgical mortality. Understanding demographic and health characteristics of patients and the associations of these characteristics with morbidity and mortality events is important in guiding care decisions. Therefore, the objectives of this study were to: (a) describe the characteristics of cardiac surgical patients; (b) identify the associations between these characteristics and morbidity and mortality events following cardiac surgery.Entities:
Keywords: 30-day mortality; Cardiac surgery; Cardiothoracic surgical outcomes; Firth logistic regression model; In-hospital mortality; Intra-surgical mortality; Kenya; Open heart surgery; Out-of-hospital mortality; Patient characteristics
Year: 2021 PMID: 34026344 PMCID: PMC8117927 DOI: 10.7717/peerj.11191
Source DB: PubMed Journal: PeerJ ISSN: 2167-8359 Impact factor: 2.984
Selected demographic characteristics and co-morbidities of cardiac surgical patients seen at a tertiary Hospital in Kenya, 2008–2017.
| Male | 37.3 | 45.2 |
| Female | 62.7 | 54.8 |
| 0 | 30.0 | 45.2 |
| 1 | 43.3 | 35.5 |
| 2 to 3 | 19.4 | 16.1 |
| 4 to 6 | 7.3 | 0.0 |
| 7 to 10 | 0.0 | 3.2 |
| Alcohol | 22.7 | 3.2 |
| Smoking | 9.3 | 3.2 |
| Khat | 2.7 | 0.0 |
| Other | 0.0 | 0.0 |
| Underweight | 10.7 | 87.1 |
| Healthy weight | 50.0 | 12.9 |
| Overweight/Obese | 39.3 | 0.0 |
| Human Immunodeficiency Virus (HIV) | 3.4 | 0.0 |
| Diabetes mellitus | 7.3 | 0.0 |
| Hypertension | 16.7 | 6.5 |
| Nephropathy | 6.7 | 0.0 |
| Thyroid derangement | 4.0 | 3.2 |
| 1 or 2 | 55.4 | 74.2 |
| 3 to 6 | 44.6 | 25.8 |
| Congenital | 5.3 | 45.2 |
| Acquired | 91.3 | 41.9 |
| Both congenital and acquired | 3.3 | 12.9 |
| 0 to 2 | 76.0 | 96.8 |
| 3 to 5 | 24.0 | 3.2 |
Selected co-morbidities and their unadjusted (univariable) associations with 30-day mortality among cardiac surgical patients seen at a tertiary hospital in Kenya, 2008–2017.
| BMI >85th percentile (overweight/obesity) | 39.3 | 0.0 | – | |
| Atrial fibrillation | 38.0 | 6.5 | .701 | |
| Heart failure with reduced ejection fraction | 24.0 | 12.9 | .106 | |
| Hypertension | 16.7 | ..273 | 6.5 | |
| Chronic obstructive pulmonary disease | 10.0 | .174 | 6.5 | .701 |
| Diabetes | 7.3 | .251 | 0.0 | – |
| Nephropathy | 6.7 | 1.000 | 0.0 | – |
| Lower respiratory tract infection | 4.0 | .579 | 0.0 | – |
| Human immunodeficiency virus | 3.3 | .447 | 0.0 | – |
| Peripheral vascular disease | 3.3 | .448 | 0.0 | – |
Notes.
Based on Chi-square test.
Selected cardiac defect types and their association with 30-day mortality among cardiac surgical patients seen at a tertiary hospital in Kenya, 2008–2017.
| Atrial septal | 6.7 | 1.000 | 16.1 | .521 |
| Atrioventricular septal | 0 | – | 12.9 | .574 |
| Ebstein anomaly | 0 | – | 3.2 | .790 |
| Mitral cleft | 0.7 | .738 | 3.2 | .790 |
| Subaortic ridge | 0 | – | 6.5 | .701 |
| Tetralogy of fallot | 0 | – | 9.7 | .632 |
| Sinus of valsalva aneurysm | 0.7 | .738 | 0 | – |
| Ventricular septal defect | 1.3 | .635 | 22.6 | .338 |
| Ascending aortic aneurysm | 2.7 | .499 | 3.2 | .790 |
| Aortic regurgitation | 24.0 | .702 | 16.1 | .178 |
| Aortic stenosis | 12.7 | .935 | 0 | – |
| Bicuspid aortic valve | 0.7 | .738 | 6.5 | |
| Coronary artery disease – | 1.3 | .058 | 0 | – |
| Coronary artery disease – | 2.0 | .176 | 0 | – |
| Coronary artery disease – | 3.3 | .448 | 0 | – |
| Coronary artery disease – | 7.3 | .917 | 0 | – |
| Mitral regurgitation | 40.7 | .618 | 35.5 | .657 |
| Mitral stenosis | 57.3 | .741 | 19.4 | .474 |
| Pulmonary valve stenosis | 0 | – | 6.5 | .701 |
| Tricuspid regurgitation | 33.3 | .248 | 25.8 | .389 |
Notes.
Based on Chi-square test.
Number of surgical procedures and deaths by year among adult and pediatric cardiac surgical patients seen at a tertiary hospital in Kenya, 2008–2017.
| 2008 | 0 | 0 | 0/0 | 0 | 3 | 0 | 0/3 | 0 |
| 2009 | 4 | 0 | 0/4 | 0 | 0 | 0 | 0/0 | 0 |
| 2010 | 5 | 0 | 0/5 | 0 | 1 | 0 | 0/1 | 0 |
| 2011 | 4 | 0 | 1/4 | 25.0 | 0 | 0 | 0/0 | 0 |
| 2012 | 4 | 1 | 0/5 | 0 | 3 | 0 | 0/3 | 0 |
| 2013 | 9 | 3 | 1/12 | 8.3 | 1 | 0 | 0/1 | 0 |
| 2014 | 8 | 2 | 2/10 | 20.0 | 7 | 0 | 0/7 | 0 |
| 2015 | 2 | 2 | 0/4 | 0 | 3 | 0 | 1/3 | 33.3 |
| 2016 | 9 | 3 | 3/12 | 25.0 | 2 | 1 | 0/3 | 0 |
| 2017 | 69 | 25 | 8/94 | 8.5 | 10 | 0 | 1/10 | 10.0 |
Notes.
Number of 30-day post-surgical deaths.
Number of cardiac surgical patients.
Selected surgical procedures and their unadjusted (univariable) associations with inhospital mortality and mediastinal hemorrhage among adult cardiac surgical patients seen at a tertiary hospital in Kenya, 2008–2017.
| Acquired tricuspid regurgitation repair | 12.7 | .091 | |
| Appendectomy | 15.3 | .506 | .313 |
| Atrial septal defect closure | 6.7 | .940 | .142 |
| Aortic valve replacement | 6.0 | .850 | .355 |
| Aortic valve repair | 0.7 | .742 | .505 |
| Bentall’s procedure | 2.7 | .515 | .395 |
| Coronary artery bypass graft –1-2 grafts | 10.0 | . | .813 |
| Coronary artery bypass graft –3-4 grafts | 4.7 | .385 | .902 |
| Double valve replacement | 16.7 | .802 | .751 |
| Left atrial reduction | 28.7 | .064 | .642 |
| Left atrial thrombectomy | 7.3 | .977 | .107 |
| Maze procedure | 7.3 | .977 | .269 |
| Mitral cleft repair | 1.3 | .648 | .344 |
| Mitral valve replacement | 54.0 | .804 | .955 |
| Re-routing pulmonary veins to Left Atrium | 0.7 | .748 | .505 |
| Ventricular septal defect closure | 0.7 | .748 | .505 |
Notes.
Based on Chi-square test.
Selected post-surgical outcomes and their unadjusted (univariable) associations with cardiopulmonary bypass and use of cardioplegia among adult cardiac surgical patients seen at a tertiary hospital in Kenya, 2008–2017.
| Acute Kidney Injury | 7.1 | 6.7 | ||
| Atrial Fibrillation | 14.3 | .221 | 14.9 | .215 |
| Cardiogenic Shock | 3.6 | .543 | 3.7 | .432 |
| Days in Intensive Care Unit (>2) | 63.6 | .548 | 62.7 | .316 |
| Overall 30-day Mortality | 10.0 | 1.0. | 10.4 | .597 |
| Intra-surgical Mortality | 2.1 | .605 | 2.2 | .605 |
| In-hospital Post-operative Mortality | 9.3 | .940 | 9.7 | .654 |
| Mediastinal Hemorrhage | 30.7 | .962 | 29.9 | .531 |
| Pericardial Effusion | 15.0 | .187 | 14.9 | .345 |
| Pneumonia | 5.0 | .054 | 5.2 | .247 |
| Renal Impairment | 26.4 | 24.6 | ||
| Re-operated sternotomy | 2.1 | .640 | 2.2 | .545 |
| Re-operation | 0.7 | .789 | 0.7 | .729 |
| Days on Cardiac Ward (<4) | 56.4 | 56.7 | ||
| Resolved Diagnosis of Atrial Fibrillation | 9.3 | .221 | 9.0 | .215 |
| Resolved Diagnosis of Heart Failure | 82.1 | .341 | 82.1 | .492 |
Notes.
Cardiopulmonary bypass.
Based on Chi-square test.
Results of final models showing predictors of pre- and peri-surgical of complications among adult cardiac surgical patients seen at a tertiary hospital in Kenya, 2008–2017.
| Overall 30-day mortality | Age in years | 1.05 | 1.01 | 1.09 | .015 | .719 |
| Atrial fibrillation | 4.12 | 1.27 | 13.35 | .018 | ||
| Acute kidney injury | Atrial fibrillation | 18.25 | 3.10 | 107.58 | .001 | .874 |
| Mitral valve replacement | 0.14 | .0.03 | 0.72 | .019 | ||
| On cardiopulmonary bypass during surgery | 0.06 | 0.01 | 0.33 | .002 | ||
| In-hospital mortality | Acquired tricuspid regurgitation repair | 4.89 | 1.47 | 16.33 | .010 | . |
| Pneumonia | Lower respiratory tract infection | 10.50 | 1.52 | 72.54 | .017 | .282 |
| Age in years | 1.06 | 1.01 | 1.11 | .015 | ||
| Cardiogenic shock | Thyroid derangement | 15.35 | 1.39 | 169.79 | .026 | .508 |
| Age in years | 1.07 | 1.01 | 1.14 | .023 | ||
| Sepsis | Duration of procedure | 2.80 | 1.17 | 6.69 | .021 | |
| Stroke | Human immunodeficiency virus infection | 31.89 | 2.39 | 424.65 | .009 |
Notes.
Confidence Interval.
Based on Wald test.
Hosmer-Lemeshow Goodness-of-fit test.